Structure

Physi-Chem Properties

Molecular Weight:  609.32
Volume:  637.523
LogP:  4.756
LogD:  4.027
LogS:  -3.742
# Rotatable Bonds:  3
TPSA:  37.3
# H-Bond Aceptor:  6
# H-Bond Donor:  0
# Rings:  11
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.369
Synthetic Accessibility Score:  6.987
Fsp3:  0.425
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.522
MDCK Permeability:  1.3433733329293318e-05
Pgp-inhibitor:  0.158
Pgp-substrate:  1.0
Human Intestinal Absorption (HIA):  0.963
20% Bioavailability (F20%):  1.0
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.056
Plasma Protein Binding (PPB):  79.09571838378906%
Volume Distribution (VD):  1.751
Pgp-substrate:  10.076910972595215%

ADMET: Metabolism

CYP1A2-inhibitor:  0.064
CYP1A2-substrate:  0.292
CYP2C19-inhibitor:  0.041
CYP2C19-substrate:  0.911
CYP2C9-inhibitor:  0.015
CYP2C9-substrate:  0.093
CYP2D6-inhibitor:  0.97
CYP2D6-substrate:  0.885
CYP3A4-inhibitor:  0.733
CYP3A4-substrate:  0.933

ADMET: Excretion

Clearance (CL):  1.904
Half-life (T1/2):  0.884

ADMET: Toxicity

hERG Blockers:  0.975
Human Hepatotoxicity (H-HT):  0.929
Drug-inuced Liver Injury (DILI):  0.02
AMES Toxicity:  0.043
Rat Oral Acute Toxicity:  0.981
Maximum Recommended Daily Dose:  0.989
Skin Sensitization:  0.781
Carcinogencity:  0.67
Eye Corrosion:  0.003
Eye Irritation:  0.004
Respiratory Toxicity:  0.917

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC52801

Natural Product ID:  NPC52801
Common Name*:   Guiaflavine
IUPAC Name:   (4aR,5aS,8aS,13aS,15aR,15bR)-15-(3-ethyl-8-methoxy-7,12-dihydro-6H-indolo[2,3-a]quinolizin-5-ium-2-yl)-6-methyl-2,4a,5,5a,7,8,13a,15a,15b,16-decahydro4,6-methanoindolo[3,2,1-ij]oxepino[2,3,4-de]pyrrolo[2,3-h]quinoline-6-ium;dichloride
Synonyms:   Guiaflavine
Standard InCHIKey:  ZOQZMDXDYBAHPK-CZJFRNDDSA-M
Standard InCHI:  InChI=1S/C40H41N4O2.2ClH/c1-4-23-20-42-15-12-25-35-30(9-7-11-33(35)45-3)41-37(25)32(42)18-26(23)28-21-43-31-10-6-5-8-29(31)40-14-16-44(2)22-24-13-17-46-38(28)36(39(40)43)27(24)19-34(40)44;;/h5-11,13,18,20-21,27,34,36,38-39H,4,12,14-17,19,22H2,1-3H3;2*1H/q+1;;/p-1/t27-,34-,36-,38-,39-,40+,44?;;/m0../s1
SMILES:  CCc1cn2CCC3=c4c(=NC3=c2cc1C1=CN2c3ccccc3[C@]35[C@@H]2[C@@H]2[C@H]1OCC=C1[C@@H]2C[C@@H]5[N+](C1)(CC3)C)cccc4OC.Cl.[Cl-]
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL555473
PubChem CID:   11802688
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000279] Alkaloids and derivatives
      • [CHEMONTID:0002749] Strychnos alkaloids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO541 Strychnos guianensis Species Loganiaceae Eukaryota stem bark n.a. n.a. PMID[10395514]
NPO541 Strychnos guianensis Species Loganiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO541 Strychnos guianensis Species Loganiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT32 Organism Mus musculus Mus musculus LD100 = 100.0 mg kg-1 PMID[542486]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC52801 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7711 Intermediate Similarity NPC138830
0.7711 Intermediate Similarity NPC67904
0.7464 Intermediate Similarity NPC126066
0.7409 Intermediate Similarity NPC320147
0.7339 Intermediate Similarity NPC115588
0.7306 Intermediate Similarity NPC473743
0.7268 Intermediate Similarity NPC469740
0.723 Intermediate Similarity NPC159815
0.722 Intermediate Similarity NPC162440
0.7198 Intermediate Similarity NPC127178
0.7198 Intermediate Similarity NPC329747
0.7196 Intermediate Similarity NPC478074
0.7158 Intermediate Similarity NPC116519
0.7137 Intermediate Similarity NPC151171
0.7135 Intermediate Similarity NPC475420
0.7128 Intermediate Similarity NPC473880
0.7092 Intermediate Similarity NPC475097
0.7079 Intermediate Similarity NPC21425
0.7064 Intermediate Similarity NPC329982
0.7059 Intermediate Similarity NPC22476
0.7056 Intermediate Similarity NPC475422
0.705 Intermediate Similarity NPC98197
0.7048 Intermediate Similarity NPC473005
0.7047 Intermediate Similarity NPC70172
0.7043 Intermediate Similarity NPC473540
0.7042 Intermediate Similarity NPC475910
0.7041 Intermediate Similarity NPC139085
0.7041 Intermediate Similarity NPC214626
0.7041 Intermediate Similarity NPC251212
0.7037 Intermediate Similarity NPC473006
0.7033 Intermediate Similarity NPC329793
0.7028 Intermediate Similarity NPC472111
0.7027 Intermediate Similarity NPC469735
0.7009 Intermediate Similarity NPC469589
0.7 Intermediate Similarity NPC318525
0.7 Intermediate Similarity NPC477066
0.7 Intermediate Similarity NPC477157
0.7 Intermediate Similarity NPC477533
0.7 Intermediate Similarity NPC10653
0.7 Intermediate Similarity NPC477156
0.6978 Remote Similarity NPC223242
0.6976 Remote Similarity NPC470483
0.697 Remote Similarity NPC478081
0.6963 Remote Similarity NPC87755
0.6952 Remote Similarity NPC11017
0.6935 Remote Similarity NPC285941
0.6923 Remote Similarity NPC17437
0.6916 Remote Similarity NPC139373
0.6912 Remote Similarity NPC285841
0.6909 Remote Similarity NPC96321
0.6909 Remote Similarity NPC473041
0.6908 Remote Similarity NPC470485
0.6902 Remote Similarity NPC477155
0.6901 Remote Similarity NPC329833
0.6901 Remote Similarity NPC470484
0.6901 Remote Similarity NPC14339
0.6898 Remote Similarity NPC471304
0.6897 Remote Similarity NPC476095
0.6897 Remote Similarity NPC477067
0.6897 Remote Similarity NPC478082
0.6891 Remote Similarity NPC478080
0.6885 Remote Similarity NPC243162
0.6884 Remote Similarity NPC470931
0.6881 Remote Similarity NPC475602
0.6878 Remote Similarity NPC288110
0.6878 Remote Similarity NPC217294
0.686 Remote Similarity NPC473004
0.686 Remote Similarity NPC204970
0.6857 Remote Similarity NPC100863
0.6856 Remote Similarity NPC216816
0.6856 Remote Similarity NPC315498
0.6856 Remote Similarity NPC230942
0.6845 Remote Similarity NPC473569
0.6838 Remote Similarity NPC81939
0.6835 Remote Similarity NPC264176
0.6835 Remote Similarity NPC127996
0.6835 Remote Similarity NPC472098
0.6827 Remote Similarity NPC473178
0.6827 Remote Similarity NPC302001
0.6822 Remote Similarity NPC285558
0.6822 Remote Similarity NPC87714
0.6818 Remote Similarity NPC85482
0.6814 Remote Similarity NPC249405
0.6809 Remote Similarity NPC475666
0.6808 Remote Similarity NPC295898
0.6804 Remote Similarity NPC471080
0.6804 Remote Similarity NPC469592
0.6797 Remote Similarity NPC131977
0.6794 Remote Similarity NPC243626
0.6789 Remote Similarity NPC206592
0.6784 Remote Similarity NPC471294
0.6782 Remote Similarity NPC287588
0.6767 Remote Similarity NPC301501
0.6766 Remote Similarity NPC260075
0.6765 Remote Similarity NPC179704
0.6763 Remote Similarity NPC105055
0.6763 Remote Similarity NPC22689
0.6758 Remote Similarity NPC251160
0.6758 Remote Similarity NPC94157
0.6755 Remote Similarity NPC264589
0.6749 Remote Similarity NPC190461
0.6746 Remote Similarity NPC203972
0.6741 Remote Similarity NPC477532
0.674 Remote Similarity NPC470126
0.6738 Remote Similarity NPC469450
0.6732 Remote Similarity NPC473007
0.673 Remote Similarity NPC161804
0.6726 Remote Similarity NPC222046
0.6725 Remote Similarity NPC475253
0.672 Remote Similarity NPC470925
0.6717 Remote Similarity NPC33507
0.6715 Remote Similarity NPC477186
0.6714 Remote Similarity NPC230313
0.6713 Remote Similarity NPC246140
0.6713 Remote Similarity NPC195787
0.6712 Remote Similarity NPC208284
0.6711 Remote Similarity NPC162748
0.6701 Remote Similarity NPC24954
0.6699 Remote Similarity NPC33902
0.6699 Remote Similarity NPC276674
0.6697 Remote Similarity NPC476116
0.6696 Remote Similarity NPC475720
0.6696 Remote Similarity NPC474192
0.6695 Remote Similarity NPC131486
0.6683 Remote Similarity NPC312531
0.6683 Remote Similarity NPC174629
0.6683 Remote Similarity NPC474059
0.6683 Remote Similarity NPC84478
0.6682 Remote Similarity NPC10732
0.6682 Remote Similarity NPC267423
0.6682 Remote Similarity NPC469594
0.6681 Remote Similarity NPC469722
0.6681 Remote Similarity NPC469451
0.6681 Remote Similarity NPC469452
0.6667 Remote Similarity NPC234772
0.6667 Remote Similarity NPC473458
0.6667 Remote Similarity NPC475147
0.6667 Remote Similarity NPC473177
0.6667 Remote Similarity NPC476651
0.6652 Remote Similarity NPC477531
0.6651 Remote Similarity NPC28510
0.6651 Remote Similarity NPC203628
0.6651 Remote Similarity NPC272706
0.6651 Remote Similarity NPC474077
0.6638 Remote Similarity NPC314954
0.6634 Remote Similarity NPC176127
0.6634 Remote Similarity NPC56618
0.6634 Remote Similarity NPC473432
0.6633 Remote Similarity NPC225319
0.6627 Remote Similarity NPC237901
0.6627 Remote Similarity NPC195788
0.6625 Remote Similarity NPC133609
0.6624 Remote Similarity NPC329932
0.6622 Remote Similarity NPC132642
0.6621 Remote Similarity NPC475133
0.6621 Remote Similarity NPC168250
0.662 Remote Similarity NPC72211
0.662 Remote Similarity NPC475774
0.6617 Remote Similarity NPC66573
0.6615 Remote Similarity NPC26850
0.6609 Remote Similarity NPC209174
0.6606 Remote Similarity NPC473180
0.6605 Remote Similarity NPC295676
0.6604 Remote Similarity NPC162653
0.6603 Remote Similarity NPC473008
0.6603 Remote Similarity NPC5630
0.6603 Remote Similarity NPC474904
0.6599 Remote Similarity NPC282339
0.6599 Remote Similarity NPC99632
0.6598 Remote Similarity NPC189079
0.6597 Remote Similarity NPC469734
0.6595 Remote Similarity NPC473105
0.6592 Remote Similarity NPC183407
0.6592 Remote Similarity NPC170114
0.6591 Remote Similarity NPC290689
0.6591 Remote Similarity NPC199667
0.6587 Remote Similarity NPC249996
0.6584 Remote Similarity NPC478083
0.6579 Remote Similarity NPC472100
0.6578 Remote Similarity NPC108826
0.657 Remote Similarity NPC476202
0.6568 Remote Similarity NPC81175
0.6567 Remote Similarity NPC160113
0.6567 Remote Similarity NPC476220
0.6565 Remote Similarity NPC252251
0.6565 Remote Similarity NPC253580
0.6565 Remote Similarity NPC311906
0.6564 Remote Similarity NPC315257
0.6564 Remote Similarity NPC280272
0.6562 Remote Similarity NPC305984
0.656 Remote Similarity NPC477161
0.6555 Remote Similarity NPC320088
0.6553 Remote Similarity NPC19679
0.6549 Remote Similarity NPC472099
0.6549 Remote Similarity NPC128115
0.6548 Remote Similarity NPC477158
0.6547 Remote Similarity NPC470549
0.6547 Remote Similarity NPC189661
0.6546 Remote Similarity NPC26872
0.6546 Remote Similarity NPC476568

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC52801 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7358 Intermediate Similarity NPD5602 Clinical (unspecified phase)
0.7259 Intermediate Similarity NPD7149 Clinical (unspecified phase)
0.7165 Intermediate Similarity NPD5680 Clinical (unspecified phase)
0.715 Intermediate Similarity NPD4118 Clinical (unspecified phase)
0.7128 Intermediate Similarity NPD5078 Clinical (unspecified phase)
0.7074 Intermediate Similarity NPD6357 Discontinued
0.7062 Intermediate Similarity NPD3984 Clinical (unspecified phase)
0.7062 Intermediate Similarity NPD3983 Phase 3
0.7041 Intermediate Similarity NPD6607 Clinical (unspecified phase)
0.702 Intermediate Similarity NPD5600 Discontinued
0.7016 Intermediate Similarity NPD6060 Clinical (unspecified phase)
0.699 Remote Similarity NPD1078 Clinical (unspecified phase)
0.6976 Remote Similarity NPD6656 Clinical (unspecified phase)
0.6974 Remote Similarity NPD4986 Clinical (unspecified phase)
0.6959 Remote Similarity NPD4796 Discontinued
0.6957 Remote Similarity NPD8016 Phase 3
0.6957 Remote Similarity NPD8017 Clinical (unspecified phase)
0.6948 Remote Similarity NPD8403 Phase 1
0.6923 Remote Similarity NPD8358 Approved
0.6916 Remote Similarity NPD7222 Phase 2
0.6905 Remote Similarity NPD5547 Clinical (unspecified phase)
0.69 Remote Similarity NPD7479 Phase 2
0.6875 Remote Similarity NPD6861 Clinical (unspecified phase)
0.6869 Remote Similarity NPD5530 Phase 1
0.6856 Remote Similarity NPD19 Approved
0.6856 Remote Similarity NPD1743 Approved
0.6856 Remote Similarity NPD1742 Approved
0.6816 Remote Similarity NPD5900 Clinical (unspecified phase)
0.681 Remote Similarity NPD7034 Discontinued
0.6798 Remote Similarity NPD5522 Clinical (unspecified phase)
0.6784 Remote Similarity NPD7710 Clinical (unspecified phase)
0.6777 Remote Similarity NPD7889 Clinical (unspecified phase)
0.6766 Remote Similarity NPD5521 Clinical (unspecified phase)
0.6765 Remote Similarity NPD7877 Suspended
0.6759 Remote Similarity NPD7453 Approved
0.6759 Remote Similarity NPD7452 Approved
0.6754 Remote Similarity NPD814 Clinical (unspecified phase)
0.6753 Remote Similarity NPD6738 Phase 2
0.6753 Remote Similarity NPD6737 Phase 2
0.6746 Remote Similarity NPD7262 Phase 1
0.6746 Remote Similarity NPD6046 Clinical (unspecified phase)
0.6721 Remote Similarity NPD8363 Approved
0.6721 Remote Similarity NPD8364 Approved
0.6683 Remote Similarity NPD6281 Approved
0.6683 Remote Similarity NPD5917 Clinical (unspecified phase)
0.6683 Remote Similarity NPD5670 Approved
0.6667 Remote Similarity NPD6526 Approved
0.6667 Remote Similarity NPD4203 Approved
0.6667 Remote Similarity NPD4204 Approved
0.6667 Remote Similarity NPD4951 Discontinued
0.6667 Remote Similarity NPD6037 Discontinued
0.6667 Remote Similarity NPD8365 Clinical (unspecified phase)
0.6667 Remote Similarity NPD1305 Clinical (unspecified phase)
0.6651 Remote Similarity NPD7671 Approved
0.6651 Remote Similarity NPD7672 Approved
0.6634 Remote Similarity NPD4354 Approved
0.6627 Remote Similarity NPD8467 Approved
0.6627 Remote Similarity NPD8427 Approved
0.6627 Remote Similarity NPD8429 Approved
0.6627 Remote Similarity NPD8466 Approved
0.6627 Remote Similarity NPD8465 Approved
0.6627 Remote Similarity NPD8428 Approved
0.6625 Remote Similarity NPD6503 Clinical (unspecified phase)
0.6623 Remote Similarity NPD7676 Clinical (unspecified phase)
0.6623 Remote Similarity NPD7674 Phase 3
0.6623 Remote Similarity NPD7675 Phase 3
0.6622 Remote Similarity NPD7678 Clinical (unspecified phase)
0.6618 Remote Similarity NPD6340 Approved
0.6618 Remote Similarity NPD6339 Approved
0.6617 Remote Similarity NPD6365 Clinical (unspecified phase)
0.6608 Remote Similarity NPD7820 Phase 3
0.6606 Remote Similarity NPD7225 Discontinued
0.6605 Remote Similarity NPD6592 Clinical (unspecified phase)
0.6598 Remote Similarity NPD5617 Suspended
0.6585 Remote Similarity NPD3037 Phase 1
0.6584 Remote Similarity NPD5938 Phase 3
0.6578 Remote Similarity NPD7194 Discontinued
0.6575 Remote Similarity NPD5658 Approved
0.6573 Remote Similarity NPD6527 Approved
0.6564 Remote Similarity NPD7221 Approved
0.6564 Remote Similarity NPD7219 Approved
0.6564 Remote Similarity NPD6824 Clinical (unspecified phase)
0.6562 Remote Similarity NPD7823 Clinical (unspecified phase)
0.656 Remote Similarity NPD7174 Clinical (unspecified phase)
0.656 Remote Similarity NPD3003 Approved
0.656 Remote Similarity NPD6150 Discontinued
0.6558 Remote Similarity NPD6810 Clinical (unspecified phase)
0.6557 Remote Similarity NPD3810 Clinical (unspecified phase)
0.6557 Remote Similarity NPD4418 Discontinued
0.6557 Remote Similarity NPD7686 Clinical (unspecified phase)
0.6555 Remote Similarity NPD6608 Clinical (unspecified phase)
0.6552 Remote Similarity NPD7796 Approved
0.6552 Remote Similarity NPD7797 Approved
0.6552 Remote Similarity NPD4498 Clinical (unspecified phase)
0.6548 Remote Similarity NPD6063 Approved
0.6547 Remote Similarity NPD6140 Clinical (unspecified phase)
0.654 Remote Similarity NPD5587 Approved
0.654 Remote Similarity NPD6569 Phase 2
0.6538 Remote Similarity NPD5256 Discontinued
0.6526 Remote Similarity NPD8249 Clinical (unspecified phase)
0.6526 Remote Similarity NPD3477 Phase 2
0.6526 Remote Similarity NPD3478 Clinical (unspecified phase)
0.6523 Remote Similarity NPD8426 Approved
0.6523 Remote Similarity NPD8425 Approved
0.6523 Remote Similarity NPD8459 Approved
0.6523 Remote Similarity NPD8460 Approved
0.6522 Remote Similarity NPD3109 Approved
0.6522 Remote Similarity NPD3110 Approved
0.652 Remote Similarity NPD3503 Approved
0.652 Remote Similarity NPD3504 Approved
0.6514 Remote Similarity NPD31 Approved
0.6514 Remote Similarity NPD4036 Approved
0.6514 Remote Similarity NPD4039 Approved
0.6514 Remote Similarity NPD4033 Approved
0.6514 Remote Similarity NPD4035 Approved
0.6514 Remote Similarity NPD4037 Approved
0.6514 Remote Similarity NPD4122 Approved
0.6514 Remote Similarity NPD32 Approved
0.6514 Remote Similarity NPD4038 Approved
0.6514 Remote Similarity NPD4034 Approved
0.6512 Remote Similarity NPD6874 Approved
0.6509 Remote Similarity NPD1304 Clinical (unspecified phase)
0.6507 Remote Similarity NPD6976 Clinical (unspecified phase)
0.6507 Remote Similarity NPD1033 Clinical (unspecified phase)
0.6507 Remote Similarity NPD7821 Clinical (unspecified phase)
0.6507 Remote Similarity NPD1034 Phase 3
0.6505 Remote Similarity NPD7414 Clinical (unspecified phase)
0.6504 Remote Similarity NPD3763 Approved
0.6502 Remote Similarity NPD7032 Approved
0.6498 Remote Similarity NPD6208 Discontinued
0.6495 Remote Similarity NPD5515 Phase 2
0.6495 Remote Similarity NPD8401 Approved
0.6495 Remote Similarity NPD8402 Approved
0.6495 Remote Similarity NPD8400 Approved
0.649 Remote Similarity NPD7424 Clinical (unspecified phase)
0.649 Remote Similarity NPD6021 Clinical (unspecified phase)
0.649 Remote Similarity NPD6344 Clinical (unspecified phase)
0.6488 Remote Similarity NPD3920 Phase 2
0.6486 Remote Similarity NPD6220 Phase 3
0.6484 Remote Similarity NPD6245 Phase 2
0.6479 Remote Similarity NPD6491 Clinical (unspecified phase)
0.6479 Remote Similarity NPD6251 Discontinued
0.6476 Remote Similarity NPD7291 Discontinued
0.6468 Remote Similarity NPD6991 Approved
0.6468 Remote Similarity NPD6872 Clinical (unspecified phase)
0.6468 Remote Similarity NPD6379 Discontinued
0.6462 Remote Similarity NPD3924 Approved
0.6462 Remote Similarity NPD3923 Approved
0.6462 Remote Similarity NPD3921 Approved
0.6462 Remote Similarity NPD5811 Approved
0.6462 Remote Similarity NPD3922 Approved
0.6456 Remote Similarity NPD6293 Clinical (unspecified phase)
0.6452 Remote Similarity NPD6238 Discontinued
0.645 Remote Similarity NPD6978 Phase 2
0.645 Remote Similarity NPD6977 Clinical (unspecified phase)
0.6449 Remote Similarity NPD6550 Discontinued
0.6445 Remote Similarity NPD3408 Clinical (unspecified phase)
0.6442 Remote Similarity NPD5083 Clinical (unspecified phase)
0.6438 Remote Similarity NPD4795 Phase 2
0.6429 Remote Similarity NPD5944 Phase 1
0.6429 Remote Similarity NPD6257 Clinical (unspecified phase)
0.6429 Remote Similarity NPD2383 Phase 1
0.6429 Remote Similarity NPD5945 Phase 1
0.6425 Remote Similarity NPD7020 Approved
0.6425 Remote Similarity NPD7019 Approved
0.6425 Remote Similarity NPD5845 Phase 2
0.6422 Remote Similarity NPD3515 Approved
0.6422 Remote Similarity NPD6316 Clinical (unspecified phase)
0.6422 Remote Similarity NPD5966 Clinical (unspecified phase)
0.6422 Remote Similarity NPD3516 Approved
0.6419 Remote Similarity NPD8311 Discontinued
0.6419 Remote Similarity NPD6769 Clinical (unspecified phase)
0.6419 Remote Similarity NPD6284 Clinical (unspecified phase)
0.6419 Remote Similarity NPD7238 Clinical (unspecified phase)
0.6411 Remote Similarity NPD4889 Approved
0.6404 Remote Similarity NPD4083 Discontinued
0.6402 Remote Similarity NPD3324 Clinical (unspecified phase)
0.6402 Remote Similarity NPD6590 Discontinued
0.64 Remote Similarity NPD5903 Approved
0.64 Remote Similarity NPD5902 Approved
0.64 Remote Similarity NPD6533 Clinical (unspecified phase)
0.6398 Remote Similarity NPD3349 Phase 2
0.6396 Remote Similarity NPD2789 Approved
0.6396 Remote Similarity NPD980 Clinical (unspecified phase)
0.6395 Remote Similarity NPD7589 Clinical (unspecified phase)
0.639 Remote Similarity NPD6375 Clinical (unspecified phase)
0.639 Remote Similarity NPD8359 Phase 2
0.6387 Remote Similarity NPD5754 Discontinued
0.6387 Remote Similarity NPD6506 Clinical (unspecified phase)
0.6386 Remote Similarity NPD6457 Approved
0.6384 Remote Similarity NPD3816 Phase 1
0.6384 Remote Similarity NPD3815 Phase 1
0.6383 Remote Similarity NPD7558 Phase 2
0.6383 Remote Similarity NPD6741 Clinical (unspecified phase)
0.6382 Remote Similarity NPD5599 Discontinued
0.6381 Remote Similarity NPD5565 Discontinued
0.6376 Remote Similarity NPD7566 Clinical (unspecified phase)
0.6375 Remote Similarity NPD6773 Clinical (unspecified phase)
0.6372 Remote Similarity NPD8149 Discontinued
0.6368 Remote Similarity NPD2843 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data